Loading…
* Free cash flow = OCF − net investing outflow (the filings carry no standalone capex line).
Operates in Pharma — Services. Per the activity note to the FY2024 annual report, the company provides promotional services related to medicines.
Subsidiary of Kerdzo Shezghuduli Pasukhismgeblobis Sazogadoeba AMERISOURCEBERGEN 60 INTERNATIONAL B.V. (100.0%)
| Line item | 2022 | 2023 | 2024 | CAGR |
|---|---|---|---|---|
| Total Revenue | 4,053 | 5,653 | 5,985 | +21.5% |
| Total COGS | 0 | 0 | 0 | |
| Gross Profit | 4,053 | 5,653 | 5,985 | +21.5% |
| Gross Margin | 100.0% | 100.0% | 100.0% | |
| 3,450 | 5,081 | 4,911 | +19.3% | |
| EBITDA | 603 | 572 | 1,074 | +33.4% |
| EBITDA Margin | 14.9% | 10.1% | 17.9% | |
| Total D&A | 81 | 44 | 35 | -34.4% |
| EBIT / Operating Income | 523 | 528 | 1,039 | +41.0% |
| Total Other Income | 104 | 96 | 64 | -21.8% |
| Profit Before Tax | 419 | 432 | 975 | +52.7% |
| Total Income Tax | 0 | 0 | 0 | |
| Net Profit / (Loss) | 419 | 432 | 975 | +52.7% |
| Net Margin | 10.3% | 7.6% | 16.3% |
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).